Liquidia Corp.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Liquidia Corp.
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.
/ 
Frequently asked questions
To buy Liquidia Corp. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Liquidia Corp. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Liquidia Corp. is LQDA:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Liquidia Corp. has its primary listing on NASDAQ (Small cap). You can trade Liquidia Corp. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Liquidia Corp. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Liquidia Corp. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Liquidia Corp..